Attached files

file filename
10-Q - FORM 10-Q - BIOVEST INTERNATIONAL INCd10q.htm
EX-10.8 - SECURED TERM B NOTE BETWEEN BIOVEST AND PSOURCE - BIOVEST INTERNATIONAL INCdex108.htm
EX-10.1 - TERM LOAN AND SECURITY AGREEMENT - BIOVEST INTERNATIONAL INCdex101.htm
EX-10.5 - SECURED TERM A NOTE BETWEEN BIOVEST AND VALENS US - BIOVEST INTERNATIONAL INCdex105.htm
EX-10.3 - SECURED TERM A NOTE BETWEEN BIOVEST AND PSOURCE - BIOVEST INTERNATIONAL INCdex103.htm
EX-32.1 - SECTION 906 CERTIFICATION OF CEO - BIOVEST INTERNATIONAL INCdex321.htm
EX-31.2 - SECTION 302 CERTIFICATION OF CFO - BIOVEST INTERNATIONAL INCdex312.htm
EX-10.4 - SECURED TERM A NOTE BETWEEN BIOVEST AND VALENS OFFSHORE SPV II - BIOVEST INTERNATIONAL INCdex104.htm
EX-10.2 - SECURED TERM A NOTE BETWEEN BIOVEST AND ERATO CORP - BIOVEST INTERNATIONAL INCdex102.htm
EX-10.6 - SECURED TERM A NOTE BETWEEN BIOVEST AND VALENS OFFSHORE SPV I - BIOVEST INTERNATIONAL INCdex106.htm
EX-10.7 - SECURED TERM B NOTE BETWEEN BIOVEST AND LAURUS MASTER FUND - BIOVEST INTERNATIONAL INCdex107.htm
EX-10.36 - RESIGNATION SETTLEMENT - BIOVEST INTERNATIONAL INCdex1036.htm
EX-10.11 - SECURED TERM B NOTE BETWEEN BIOVEST AND VALENS OFFSHORE SPV I - BIOVEST INTERNATIONAL INCdex1011.htm
EX-10.35 - SECURITY AGREEMENT - BIOVEST INTERNATIONAL INCdex1035.htm
EX-10.18 - WARRANT TERMINATION AGMT BETWEEN BIOVEST AND LAURUS - BIOVEST INTERNATIONAL INCdex1018.htm
EX-10.19 - WARRANT TERMINATION AGMT BETWEEN BIOVEST AND VALENS US - BIOVEST INTERNATIONAL INCdex1019.htm
EX-10.24 - ROYALTY ASSIGNMENT TERMINATION AGREEMENT BETWEEN - BIOVEST INTERNATIONAL INCdex1024.htm
EX-10.22 - ROYALTY TERMINATION AGMT AMONG BIOVEST, LV ADMINISTRATIVE AND THE LENDERS - BIOVEST INTERNATIONAL INCdex1022.htm
EX-10.32 - GRANT OF SECURITY INTEREST AGMT - BIOVEST INTERNATIONAL INCdex1032.htm
EX-10.13 - CONTINGENT PAYMENT AGREEMENT BETWEEN BIOVEST PSOURCE - BIOVEST INTERNATIONAL INCdex1013.htm
EX-10.30 - STOCK PLEDGE AGMT - BIOVEST INTERNATIONAL INCdex1030.htm
EX-10.27 - CLOSING SHARES LOCK-UP AGMT - BIOVEST INTERNATIONAL INCdex1027.htm
EX-10.34 - PLAN SECURED PROMISSORY NOTE - BIOVEST INTERNATIONAL INCdex1034.htm
EX-10.33 - GRANT OF SECURITY INTEREST IN INTELLECTUAL PROPERTY - BIOVEST INTERNATIONAL INCdex1033.htm
EX-10.10 - SECURED TERM B NOTE BETWEEN BIOVEST AND VALENS US - BIOVEST INTERNATIONAL INCdex1010.htm
EX-10.29 - GUARANTY - BIOVEST INTERNATIONAL INCdex1029.htm
EX-10.20 - ROYALTY TERMINATION AGMT AMONG BIOVEST, LV ADMINISTRATIVE, AND VALENS U.S. - BIOVEST INTERNATIONAL INCdex1020.htm
EX-10.26 - SUBORDINATION AGMT - BIOVEST INTERNATIONAL INCdex1026.htm
EX-10.17 - WARRANT TERMINATION AGMT BETWEEN BIOVEST AND LAURUS - BIOVEST INTERNATIONAL INCdex1017.htm
EX-10.16 - CONTINGENT PAYMENT AGREEMENT BETWEEN BIOVEST AND VALENS OFFSHORE SPV I - BIOVEST INTERNATIONAL INCdex1016.htm
EX-10.12 - CONTINGENT PAYMENT AGREEMENT BETWEEN BIOVEST AND ERATO - BIOVEST INTERNATIONAL INCdex1012.htm
EX-10.21 - ROYALTY TERMINATION AGMT AMONG BIOVEST, LV ADMINISTRATIVE AND THE LENDERS - BIOVEST INTERNATIONAL INCdex1021.htm
EX-10.28 - LIMITED GUARANTY - BIOVEST INTERNATIONAL INCdex1028.htm
EX-10.15 - CONTINGENT PAYMENT AGREEMENT BETWEEN BIOVEST AND VALENS US - BIOVEST INTERNATIONAL INCdex1015.htm
EX-10.23 - ROYALTY TERMINATION AGMT BETWEEN BIOVEST AND ACCENTIA BIOPHARMACEUTICALS - BIOVEST INTERNATIONAL INCdex1023.htm
EX-10.25 - SUBORDINATION AGMT - BIOVEST INTERNATIONAL INCdex1025.htm
EX-10.31 - SECURITY AGMT - BIOVEST INTERNATIONAL INCdex1031.htm
EX-32.2 - SECTION 906 CERTIFICATION OF CFO - BIOVEST INTERNATIONAL INCdex322.htm
EX-10.9 - SECURED TERM B NOTE BETWEEN BIOVEST AND VALENS OFFSHORE SPV II - BIOVEST INTERNATIONAL INCdex109.htm
EX-10.14 - CONTINGENT PAYMENT AGREEMENT BETWEEN BIOVEST AND VALENS OFFSHORE SPV II - BIOVEST INTERNATIONAL INCdex1014.htm

Exhibit 31.1

CERTIFICATIONS

I, Francis E. O’Donnell, Jr., certify that:

 

  1. I have reviewed this Quarterly Report on Form 10-Q of Biovest International, Inc.;

 

  2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

 

  3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

 

  4. The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

 

    a. Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

 

    b. Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

 

    c. Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

 

    d. Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

 

  5. The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

 

    a. All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

 

    b. Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Date: February 11, 2011

 

By:  

/s/ Francis E. O’Donnell, Jr.

  Francis E. O’Donnell, Jr., M.D.
 

Chief Executive Officer;

Chairman of the Board; Director

(Principal Executive Officer)